IDEAYA Biosciences (NASDAQ:IDYA – Get Free Report)‘s stock had its “overweight” rating restated by Cantor Fitzgerald in a ...

Fintel reports that on January 13, 2025, Cantor Fitzgerald initiated coverage of Camtek (NasdaqGM:CAMT) with a Neutral ...

The nomination of Howard Lutnick, chairman and CEO of financial services firm Cantor Fitzgerald, as Commerce Secretary signals a new chapter for the USPTO.

For 14 major ETFs, Cantor Fitzgerald compiled a weekly percent of reports coming in from the funds' constituents. The ...

A slump in Chinese consumer confidence is holding Sanlam investments' Hannah Gooch-Peters back from buying luxury stocks like LVMH. Speaking to CNBC's Silvia Amaro, the portfolio manager said she ...

Cantor Fitzgerald raised the firm’s price target on MicroStrategy (MSTR) to $613 from $581 and keeps an Overweight rating on the shares.

Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Money Movers' to discuss Johnston's thesis for ...

Cantor Fitzgerald initiated coverage of Camtek (CAMT) with a Neutral rating and $100 price target Stay Ahead of the Market:Discover ...

In recent trading, Aurinia Pharmaceuticals Inc (AUPH) stock price has shown some volatility, fluctuating -9.02% over the last five trades and -25.57% over the past 30 trades. This represents a notable ...

Cantor Fitzgerald assumed coverage on shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) in a research note published on Friday morning, Marketbeat reports. The firm issued an overweight ...

Humacyte Inc’s profitability metrics reveal financial health. The company currently boasts a gross margin of -37.20%. The profit margin, also known as the revenue ratio or gross profit ratio, measures ...